Table 4.
Clinical parameters.
| Variable | Study Timepoints | Control Group | Test Group | p between Groups |
|---|---|---|---|---|
| FMBS Mean ± SD |
Baseline | 0.41 ± 0.3 | 0.42 ± 0.3 | NS |
| M1 | 0.09 ± 0.06 | 0.07 ± 0.09 | NS | |
| M3 | 0.18 ± 0.14 | 0.19 ± 0.05 | NS | |
| M6 | 0.15 ± 0.11 | 0.12 ± 0.07 | NS | |
|
p intra-group (M6 vs. Baseline) |
p < 0.01 | p < 0.01 | ||
| FMPS Mean ± SD |
Baseline | 0.55 ± 0.37 | 0.45 ± 0.22 | NS |
| M1 | 0.23 ± 0.17 | 0.29 ± 0.19 | NS | |
| M3 | 0.25 ± 0.19 | 0.28 ± 0.09 | NS | |
| M6 | 0.13 ± 0.11 | 0.25 ± 0.17 | NS | |
|
p intra-group (M6 vs. Baseline) |
p < 0.001 | p < 0.01 | ||
| PPD Number (#) sites ≥ 4 mm Mean (95%CI) |
Baseline | 49.64 (27.75–71.52) |
67.70 (48.44–86.96) |
NS |
| M3 | 24,73 (12.19–37.26) |
36,20 (22.47–49.93) |
NS | |
| M6 | 20.45 (8.93–31.98) |
24.80 (12.71–36.89) |
NS | |
|
p intra-group (M6 vs. Baseline) |
p < 0.01 | p < 0.001 | ||
| Difference in PPD # sites ≥ 4 mm Mean (95%CI) |
M3 vs. Baseline | 24.91 (14.28–35.54) |
31.50 (17.80–45.20) |
NS |
| M6 vs. Baseline | 29.18 (16.76–41.60) |
42.90 (29.82–55.98) |
NS (p = 0.072) |
#: Stays for number of sites. FMBS: full mouth bleeding score; FMPS: full mouth plaque score; PPD: probing pocket depth.